Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
Reaction mass of 5,5'-{(phenylmethanediyl)bis[benzene-4,1-diyl-diazene-2,1-diyl]}bis{1-[3-(dimethylamino)propyl]-4-methyl-6-oxo-3-(pyridinium-1-yl)-1,6-dihydropyridin-2-olate} hydrochloride and 5,5’-[3,4’-(phenylmethanediyl)diphenylene]bis(diazene-2,1-diyl)bis{1-[3-(dimethylamino)propyl]-4-methyl-6-oxo-3-(pyridinium-1-yl)-1,6-dihydropyridin-2-olate} hydrochloride
EC number: 700-312-3 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2009-12-07 to 2010-08-20
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline-conform study under GLP without deviations.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian cell gene mutation assay
- Target gene:
- HPRT (hypoxanthine-guanine phosphoribosyl transferase) catalyzes the conversion of the nontoxic 6-TG (6-thioguanine) to its toxic ribophosphorylated derivative. Therefore, cells deficient in HPRT due to a forward mutation are resistant to 6-TG. These cells are able to proliferate in the presence of 6TG whereas the non-mutated cells die. However, the mutant phenotype requires a certain period of time before it is completely expressed. The phenotypic expression is achieved by allowing exponential growth of the cells for 7 - 9 days. The expression period is terminated by adding 6-TG to the culture medium.
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- - Type and identity of media: Large stocks of the V79 cell line (supplied by Laboratory for Mutagenicity Testing; Technical University Darmstadt, Germany) are stored in liquid nitrogen in the cell bank of Harlan CCR allowing the repeated use of the same cell culture batch in experiments. Thawed stock cultures are propagated at 37 °C in 80 cm2 plastic flasks. About 15 ml MEM (minimal essential medium; SEROMED, Berlin, Germany) supplemented with 10 % fetal bovine serum (FBS; PAA Laboratories GmbH, 35091 Cölbe, Germany) and 1 % neomycin.
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: yes
- Periodically "cleansed" against high spontaneous background: yes - Additional strain / cell type characteristics:
- other: cells deficient in HPRT
- Metabolic activation:
- with and without
- Metabolic activation system:
- Mammalian Microsomal Fraction S9 Mix
- Test concentrations with justification for top dose:
- Concentrations in µg/ml
Experiment I
Without S9 mix*: 95, 190, 380, 760, 1140, 1520
With S9 mix*: 190, 380, 760(p), 1140(p), 1520(p), 1900(p)
Experiment II
Without S9 mix**: 50, 100, 200, 400, 600, 800
With S9 mix*: 100, 200(p), 400(p), 800(p), 1200(p), 1400(p)
* 4 hours treatment ** 24 hours treatment p = precipitation
In the first main experiment the cultures at the lowest concentration of 95 µg/mL without metabolic activation and 190 µg/mL with metabolic activation were not continued since a minimum of only four analysable concentrations is required by the guidelines. The cultures at the highest concentration of 1900 µg/mL in the presence of metabolic activation were not continued due to exceedingly severe toxic effects. In experiment II the cultures at 1400 µg/mL with metabolic activation were not continued to avoid analysis of too many precipitating concentrations. The cultures at 50 µg/mL without metabolic activation were not continued since a minimum of only four analysable concentrations is required by the guidelines. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: water
- Justification for choice of solvent/vehicle: The solvent was chosen according to its solubility properties and its relative nontoxicity to the cells. - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: Without metabolic activation: EMS, ethylmethane sulfonate; With metabolic activation: DMBA, 7,12-dimethylbenz(a)anthracene
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration: Experiment I: 4 hours (serum free medium with test item); Experiment II: 24 hours (test item in complete medium)
- Expression time (cells in growth medium): 15 days
- Selection time (if incubation with a selection agent): 7 days
SELECTION AGENT (mutation assays): 6-TG (6-thioguanine)
NUMBER OF REPLICATIONS: 2 replicates per test item concentration
NUMBER OF CELLS EVALUATED: Cell suspensions were seeded into plastic culture flasks. Approximately 1.5×10^6 (single culture) and 5×10^2 cells (in duplicate) were seeded in MEM with 10 % FBS (complete medium) for the determination of mutation rate and toxicity, respectively.
DETERMINATION OF CYTOTOXICITY
- Method: Cytotoxic effects as indicated by a relative cloning efficiency of less than 50 % in both parallel cultures occurred in experiment I at 1140 µg/mL and above without metabolic activation and at 1520 µg/mL and above with metabolic activation. In experiment II cytotoxic effects as described above were noted at 800 µg/mL without metabolic activation (24 hours treatment).
OTHER EXAMINATIONS:
- Determination of polyploidy: not applicable
- Determination of endoreplication: not applicable
- Other: mutation rates, cloning efficiency survival, cloning efficiency viability - Evaluation criteria:
- Acceptability of the Assay
The gene mutation assay is considered acceptable if it meets the following criteria:
- the numbers of mutant colonies per 106 cells found in the solvent controls fall within the laboratory historical control data range.
- the positive control substances must produce a significant increase in mutant colony frequencies.
- the cloning efficiency II (absolute value) of the solvent controls must exceed 50 %.
The data of this study comply with the above mentioned criteria (as demonstrated in the annexes of attached to the study report).
Evaluation of Results
A test item is classified as positive if it induces either a concentration-related increase of the mutant frequency or a reproducible and positive response at one of the test points. A test item producing neither a concentration-related increase of the mutant frequency nor a reproducible positive response at any of the test points is considered non-mutagenic in this system.
A positive response is described as follows: A test item is classified as mutagenic if it reproducibly induces a mutation frequency that is three times above the spontaneous mutation frequency at least at one of the concentrations in the experiment.
The test item is classified as mutagenic if there is a reproducible concentration-related increase of the mutation frequency. Such evaluation may be considered also in the case that a threefold increase of the mutant frequency is not observed.
However, in a case by case evaluation this decision depends on the level of the corresponding solvent control data. If there is by chance a low spontaneous mutation rate within the laboratory´s historical control data range, a concentration-related increase of the mutations within this range has to be discussed. The variability of the mutation rates of solvent controls within all experiments of this study was also taken into consideration. - Statistics:
- A linear regression (least squares) was performed to assess a possible dose dependent increase of mutant frequencies using SYSTAT11 statistics software. The number of mutant colonies obtained for the groups treated with the test item were compared to the solvent control groups. A trend is judged as significant whenever the p-value (probability value) is below 0.05. However, both, biological and statistical significance were considered together.
experimental group: p-value
experiment I, culture I without S9 mix: 0.975
experiment I, culture II without S9 mix: 0.073
experiment I, culture I with S9 mix: 0.333
experiment I, culture II with S9 mix: 0.555
experiment II, culture I without S9 mix: 0.354
experiment II, culture II without S9 mix: 0.080
experiment II, culture I with S9 mix: 0.265
experiment II, culture II with S9 mix: 0.328 - Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- No relevant and reproducible increase in mutant colony numbers/106 cells was observed in the main experiments up to the maximum concentration. The induction factor did not reach or exceed the threshold of 3.0.
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- Experiment I: at 1140 µg/mL and above without metabolic activation, at 1520 µg/mL and above with metabolic activation. Experiment II: at 800 µg/mL without metabolic activation (24 hours treatment)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: There was no relevant shift of pH of the medium even at the maximum concentration of the test item.
- Effects of osmolality: There was no relevant shift of osmolarity of the medium even at the maximum concentration of the test item.
- Evaporation from medium: no observations reported
- Water solubility: test item basically well soluble in water
- Precipitation: Precipitation of the test item was noted at 760 µg/mL and above in the first experiment with metabolic activation. In experiment II precipitation was noted at 200 µg/mL and above with metabolic activation.
- Other confounding effects: none reported
RANGE-FINDING/SCREENING STUDIES:
A pre-test was performed in order to determine the concentration range for the mutagenicity experiments. The general culture conditions and experimental conditions in this pre-test were the same as described for the mutagenicity experiment below. In this pre-test the colony forming ability of approximately 500 single cells (duplicate cultures per concentration level) after treatment with the test item was observed and compared to the controls. Toxicity of the test item is indicated by a reduction of the cloning efficiency (CE).
COMPARISON WITH HISTORICAL CONTROL DATA:
The mutation frequency slightly exceeded the historical range of solvent controls at some of the test points. Neither one of those minor increases was dose dependent as indicated by the lacking statistical significance.
ADDITIONAL INFORMATION ON CYTOTOXICITY: none - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Interpretation of results (migrated information):
negative
Under the experimental conditions reported the substance registered did not induce gene mutations at the HPRT locus in V79 cells. Therefore, the test item is considered to be non-mutagenic in this HPRT assay. - Executive summary:
The registered substance was assessed for its potential to induce gene mutations at the HPRT locus using V79 cells of the Chinese hamster. The study followed the protocol as given in OECD Guideline 476.
The study was performed in two independent experiments, using identical experimental procedures. In the first experiment the treatment period was 4 hours with and without metabolic activation. The second experiment was performed with a treatment time of 4 hours with and 24 hours without metabolic activation.
The cell cultures were evaluated at the following concentrations:
Experiment I: without S9 mix: 190; 380; 760; 1140; and 1520 µg/mL; with S9 mix: 190; 380; 760; 1140; and 1520 µg/mL Experiment II: without S9 mix: 100; 200; 400; 600; and 800 µg/mL; with S9 mix: 100; 200; 400; 800; and 1200 µg/mL
Precipitation of the registered substance was noted at 760µg/mL and above in the first experiment with metabolic activation. In experiment II precipitation was noted at 200µg/mL and above with metabolic activation.
Cytotoxic effects as indicated by a relative cloning efficiency of less than 50 % in both parallel cultures occurred in experiment I at 1140 µg/mL and above without metabolic activation and at 1520 µg/mL and above with metabolic activation. In experiment II cytotoxic effects as described above were noted at 800 µg/mL without metabolic activation (24 hours treatment).
No relevant and reproducible increase in mutant colony numbers/10^6 cells was observed in the main experiments up to the maximum concentration. The induction factor did not reach or exceed the threshold of 3.0.
The mutation frequency slightly exceeded the historical range of solvent controls at some of the test points. Neither one of those minor increases was dose dependent as indicated by the lacking statistical significance.
A linear regression analysis (least squares) was performed to assess a possible dose dependent increase of mutant frequencies using SYSTAT11 statistics software. No significant dose dependent trend of the mutation frequency indicated by a probability value of <0.05 was determined in any of the experimental groups.
In both experiments of this study (with and without S9 mix) the range of the solvent controls was from 9.7 up to 25.9 mutants per 10^6 cells; the range of the groups treated with the test item was from 7.9 up to 40.7 mutants per 10^6 cells.
EMS (225 µg/mL in experiment I and 150 µg/mL in experiment II) and DMBA (1.1 µg/mL) were used as positive controls and showed a distinct increase in induced mutant colonies.
In conclusion it can be stated that under the experimental conditions reported the registered substance did not induce gene mutations at the HPRT locus in V79 cells. Therefore, the registered substance is considered to be non-mutagenic in this HPRT assay.
Reference
A linear regression analysis (least squares) was performed to assess a possible dose dependent increase of mutant frequencies using SYSTAT11 statistics software. No significant dose dependent trend of the mutation frequency indicated by a probability value of <0.05 was determined in any of the experimental groups.
In both experiments of this study (with and without S9 mix) the range of the solvent controls was from 9.7 up to 25.9 mutants per 10^6 cells; the range of the groups treated with the test item was from 7.9 up to 40.7 mutants per 10^6 cells.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Two in-vitro mutagenicity studies on the registered substance are available. These are supplemented by two in-vitro genotoxicity studies conducted on the analogue substance. A full justification for the appropriateness of the performed read-across approach is given as an appendix in chapter 13 of this dossier.
Two valid reverse bacterial mutation assays have been conducted, one guideline-conform Ames Test on the registered substance and one guideline-conform Ames Test on the analogue substance. Both gave a negative result in the presence and in the absence of exogenous metabolic activation. In a valid chromosomal aberration assay with and without metabolic activation conducted on the analogue substance, the test result was "not genotoxic". Furthermore, the valid mammalian gene mutation assay (HPRT) conducted on the registration substance, likewise revealed a negative result with and without S9-mix. Overall, a very consistent database of negative mutagenicity / genotoxicity test data is available for both, the analogue as well as the registration substance, which further substantiate the read-across approach used. Based hereupon, it is concluded that the registration substance is not mutagenic / genotoxic with and without exogenous metabolic activation.
Justification for selection of genetic toxicity endpoint
Guideline-conform study under GLP without deviations
Justification for classification or non-classification
The available in-vitro genotoxicity studies on the registered and the analogue substance revealed all negative results. On this basis the substance registered is not to be classified as to its genotoxic properties.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)